The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
AVCT SP has historically increased on the day shares are released to market.
This is the kind of news that makes PIs hold off, not investment companies.
Like it or not, AVCT had a pile on from PIs which sent it upwards and it was then rapidly dropped to meet the placing price by traders. PIs won't be back in droves, expecially with news like this.
However, that's not necessarily an issue because we've seen the likes of US investment houses coming in strong. I wouldn't be surprised to see more TR1s as AVCT moves forward in the coming weeks. This comes with a whole new set of challenges for PIs, and makes it a tricky share to day trade for PIs too.
So for me, it becomes a strong hold. There's news coming, we know this. SP will reflect that, but as we saw yesterday without PIs piling in on good news in the numbers they were previously (often called rainbow chasers, but they are what drives up the price), it leaves the professionals more scope to control how fast it climbs. Plus there are plenty of PIs left stranded on higher buy-in prices (we saw the 140s bow out yesterday, there will be others at 150/5, 180 and 200+) which will increase resitance at those points.
Personally I think this is going up, but on a much more controlled tangent than it has done previously. And when news is proven this time, not on anticipation of news - as before.
If they can do what they say they can do AND get it to market without delays, we'll break the previous highs. But talk of £5 and £10 relies on the cancer treatments, and is a much longer term hold.
Stock exchange shows it at 134.5 but it went to closing aution and then closing price crossing. Will settle down in a few minutes and we'll see.
Even so, I'd have expected us to be testing 150 today with this level of news. People are wary.
134.5 it closed. That's what London Stock Exchange shows. Google shows the last trade - nothing more.
Closed with a sub-10% increase on the news that a third party has verified AVCT's findings that they have found a cure and/or treatment for Covid.
Goes to show that the market really needs to see some actual, tangible product at this point. Prospects and hype just aren't doing it any more.
On the flip side, if you're confident AVCT are going to deliver then when they do suddenly drop news of a working prototype and/or a signed agreement wtih a large scale development partner then this will rocket.
0O8X ticker for Wirecard.
Big gamble, that.
Looks like we're going to need 4 or 5 attempts to get through 140 and hold there. Still got a couple of hours to get there but would be nice to see that gone today.
Sign of strength that we're getting as many as 4 or 5 attempts without it drifting right back.
It was already almost 60% higher than it is currently a couple of weeks ago on less news.
If big pharma tie ups are announced around the same time as the Cytiva test we're well past those numbers.
Of course, until it's a done deal, it's still a risk, but you can't deny it looks like wheels are properly in motion now.
JDT1990 - The way the placing was done left a very sour taste in a lot of PIs mouths - everything about it screamed “up yours” to PIs.
I’m still here - it’s still money at the end of the day and there’s more to come in the mid-term. But AVCT is now a much smaller part of my portfolio than it was, because if placing news can be leaked so easily what else will be put to market before we find out? Not a problem when it’s good news, but if a problem crops up...
There are those in here who were shafted. Shafted by the placing, shafted by the insider trading that took it down from 200 to 124 in the days prior to the placing being announced, those who got in at 120 on the placing only to see the stock shorted down to 97.
These people won’t be interested in the future, they just want some salve for their burns and their money back.
Anyone who spent the week watching their 120 investment drop to 97 will likely consider 134 this morning a welcome and unexpected profit and bow out.
The same will happen at 150, 180 and a stampede at 200.
The markets will show how they feel about this news (which still isn’t the news most are waiting for), but people should be prepared for serious resistance at certain levels as PIs jump out - vowing never to return to AIM.
So today the share stabalised back to where it needs to be based on the placing price. Now it will face resistance and then people will go again trying to force it down to bully folks out of their position. It's simple playground bullying - just with your real money this time.
If you believe in the company, then log off, make a coffee, and come back later to see what the Cytiva presentation has to say (though don't expect miracles - they won't be able to say anything overtly that isn't already public knowledge).
Assuming this stabalises aronud 125-130 today I can see 150 being breached again when good news comes regarding the Cytiva test. If that news doesn't come this week, we can expect stop losses to be tested once again. That's the cycle - and the fewer PIs who get spooked when that happens, the smaller that drop each time will become.
It could also show that a deal is about to be tabled for initial discussions, and that director needs to be out before that happens.
A lot of ifs and buts available with things like this, but as has been said downthread - largely irrelevant in the grand scheme of things - at least until more information is available.
Picture a geyser.
Of course, beware the excitable rhetoric. But most holders here are expecting this to breach the 100 mark soon enough (though by soon I mean 'this summer' rather than 'by Thursday').
Jedi these people are not. Nor are they Sith.
Just storm troopers making a nuisance of themselves.
Similar story across the board, it seems. GDR are down today so a similar SP as AVCT - and they come from a high of over 300. NCYT are having a better day but their SP is almost 60% down on their peak of 529.
Ultimately, either you believe Covid will continue to be an issue and these tests are still required, or you don't. If you don't, and you're still in, then it has to be for the cancer treatment which is a much longer term hold.
My point being that if you do beleive Covid will continue to be an issue or you're here for the cancer, today's SP shouldn't really concern you at all.
Doesn't seem to quite have the strength to maintain a presence above 75p today. Hopefully the US can help us over the line. Failing that, likely a retrace to 71 and then try again another day.
Markets attacking PIs trying to fill large buy orders at an aggressive price. Facilitated by Covid stocks all being down today and markets in general having a tough time, the manipulation was easier to achieve.
Large investors selling in the background because they’ve been tipped off something is amis at AVCT.
All our research was for nought and AS has shafted us all with one of the biggest scams in history.
Take your pick - you’ll find people on this board who will argue any of the above.
“ it shows all the tell-tale signs of an orchestrated raid.”
Unfortunately this tallies with my experience, also. The buys today are in sizeable, rounded chunks. The sells are typically random numbers - which whilst not always the case does resemble PI sales and investment company purchases.
With this now being a secondary share in my portfolio (though still a good amount invested), I’m happy to consider it a long hold and let it do its thing. But it really does smack of markets corralling PIs and then savaging them.
Well, what a day. I honestly didn't think this would be allowed to finish so far short of 120.
Ironically I find myself relieved that I reduced my position here when the placing was announced as the insider trading left a sour taste. I do sincerely hope that's not the case here and it's simply an aggressive buy being filled along with a very sour covid market today. No interest in selling my remaining shares anywhere near this price, but we do have to consider whether this is now being looked at as a cancer treatment play by the markets, rather than a covid one.
Of course, an announcement that restrictions are being reintroduced in local lockdowns plus an RNS stating the prototype is ready to go and things may change. But I don't think anyone can argue some serious questions need answering today.
A huge placing investment has come from a large US investment company - and regardless of what went on behind the scenes to grease the wheels for that deal - it went ahead at 120.
This won't be allowed to stray far from that number, and if it does, I think we can assume large holders have been made aware bad news is coming and are jumping. But as it stands, irritating as it is to see profit so far down, nothing has changed. This will float about dipping and peaking until we get some significant news, which should be in the next couple of weeks.
Until then, unless you're day trading getting worked up about these peaks and troughs is just going to cause you unnecessary stress.